Ginseng (the root of Panax ginseng C. A. MEYER, family Araliaceae) is frequently used as a traditional medicine, taken orally, in China, Korea, Japan and other Asian countries.
To explain these pharmacological actions, it is thought that ginseng saponins must be metabolized by human intestinal bacteria after their oral administration. [8] [9] [10] [11] [12] For example, ginsenoside Rb1, Rb2 and Rc are transformed to 20-O-b-D-glucopyranosyl-20(S)-protopanaxadiol (compound K) by human intestinal bacteria, with ginsenoside Re transformed to protopanaxatriol.
Akao et al. reported that compound K was detected in the blood after the oral administration of ginsenoside Rb1 to rats. 8, 10) We also reported that compound K was detected in the urine when ginsenoside Rb1 was orally administered to rats. 13) Tawab et al. reported that ginsenoside F1, compound K and ginsenoside Rh1 were detected in the urine and blood when ginseng extract was orally administered to humans. 14) These results suggest that protopanaxadiol ginsenosides may be metabolized, mainly to compound K, and protopanaxatriol ginsenosides to ginsenoside Rh1 and ginsenoside F1. Thus, these findings are in contrast with the report of Hasegawa et al. who suggested that ginsenoside Re was metabolized mainly to protopanaxatriol by human intestinal microflora. 15 ) Therefore, to clarify the metabolism of the ginsenoside Re by human intestinal microflora, the ginsenoside Re-metabolizing intestinal bacteria were isolated from human feces, their metabolic activity measured and the estrogenic effect of ginsenoside Re, as well as its main metabolites, investigated.
MATERIALS AND MEHTODS

Materials The p-nitrophenyl-b-D-glucopyranoside (PNG),
p-nitrophenyl-a-L-rhamnopyranoside (PNR), sulforhodamine B (SRB), NP40, 17b-estradiol, Dulbecco's modified Eagles medium (DMEM), fetal bovine serum (FBS) and charcoal dextran stripped FBS (CD-FBS) were purchased from Sigma Chem. Co. (U.S.A.). The general anaerobic medium (GAM) was purchased from Nissui Pharmaceutical Co., Ltd., (Tokyo, Japan). The tryptic soy broth (TS) and other media were purchased from Difco Co. (U.S.A.). The protein assay reagent was purchased from Bio-Rad Laboratories (U.S.A.). The enhanced chemiluminescence (ECL) kit was purchased from Amersham Co. (U.S.A.). The progesterone receptor (PR) was purchased from Santa Cruz Co. (U.S.A.). The protease inhibitor cocktail was purchased from Roche Co. (Germany). The poncirin, poncirenin and ponciretin were isolated as previously described.
16) The ginsenosides Re and Rg2 were isolated according to the previously described method. 3, 15) All other chemicals were of analytical reagent grade, and all solutions used after redistillation.
Isolation of Ginsenoside Re-hydrolyzing Bacteria from Human Intestinal Bacteria A suspension of the fresh feces of a healthy Korean man was diluted 10 5 to 10 8 -fold with GAM medium. A sample (200 ml) of the diluted human feces was streaked onto a GAM agar plate, and then anaerobically incubated at 37°C for 3 d. Each colony was cultured in GAM broth and assayed for ginsenoside Re-transforming activity. The bacteria were identified using Bergey's manual. 17) Ginsenoside Re-hydrolyzing bacteria were first cultured in GAM broth, inoculated into 50 ml TS and then anaerobically cultured for 21 h. The bacterial growth and ginsenoside Retransforming activity were measured.
Assay of the Activity Metabolizing Ginsenoside Re A reaction mixture, containing 100 ml of 1 mM ginsenoside Re, 100 ml of the enzyme and 300 ml of 50 mM phosphate buffer (pH 7.0), was incubated for 1, 5 and 12 h at 37°C. The reaction mixture was extracted with ethyl acetate, evaporated and finally assayed by TLC: TLC plates, silica gel 60F 254 (Merck Co., U.S.A.); developing solvent, CHCl 3 -MeOH-H 2 O (65 : 35 : 10 v/v, lower phase). The plates were stained by spraying with MeOH-H 2 SO 4 (95 : 5 v/v), followed by heating. The stained TLCs were then analyzed using a TLC scanner (Shimadzu model CS-9301PC, Japan).
Isolation of Ginsenoside Re and Its Metabolites by Human Intestinal Microflora Fresh human feces (5 g) was suspended in 100 ml of TS broth, centrifuged at 500ϫg for 10 min, the resulting supernatant centrifuged at 10000ϫg for 30 min, and then washed twice with TS broth. The resulting precipitate was suspended in 100 ml of 20 mM phosphate buffer (pH 7.0), containing 150 mg of ginsenoside Re (purity, Ͼ90%), incubated for 24 h at 37°C, and extracted with BuOH. This BuOH fraction was subjected to chromatography on a silica gel column, using CHCl 3 -MeOH-H 2 O (10 : 3 : 1, lower layer) as eluent, to isolate protopanaxatriol (2 mg; purity, Ͼ90%), ginsenoside F1 (3 mg; purity, Ͼ95%), ginsenoside Rh1 (8 mg; purity, Ͼ95%) and ginsenoside Rg1 (15 mg; purity, Ͼ90%). The purities of the isolated ginsenosides were assayed by HPLC [Hitachi HPLC system: column, Lichrosorb NH 2 (25ϫ0. Assay of Enzyme Activity To assay the activity of arhamnosidase, a reaction mixture, containing 300 ml of 50 mM phosphate buffer, 100 ml of 1 mM PNR (other substrates) and 100 ml of the enzyme, was incubated for 15 min at 37°C. For the b-glucosidase activity assay, PNG was used as the substrate. The reaction was stopped by the addition of 500 ml of 0.5 M NaOH, and the absorbance measured at 405 nm using a UV spectrophotometer (Shimadzu UV-120-02, Japan).
Purification of a a-Rhamnosidase and b b-Glucosidase from Bacteroides JY-6 Bacteroides JY-6 was cultured in 10 l of tryptic soy broth, containing 0.1% ascorbic acid and 0.01% sodium thioglycolate, at 37°C for 21 h under anaerobic conditions, and harvested by centrifugation for 30 min at 5000 rpm at 4°C. The pellets were washed twice with cold 50 mM sodium phosphate buffer, suspended in 150 ml of the same buffer, at pH 7.0, and the suspended cells ultrasonicated on ice for 15 min (100 watt, 60% pulsed mode). The disrupted cells were centrifuged at 10000ϫg for 60 min, and the supernatant used as a crude enzyme solution. The crude enzyme was precipitated with 70% saturated ammonium sulfate and centrifuged at 10000ϫg at 4°C for 60 min. The pellets were resuspended in 70 ml of 50 mM sodium phosphate buffer and applied to a butyl toyoperal column, according to the previously reported methods. 18, 19) The specific activity of the partially purified a-rhamnosidase and b-glucosidase were 1.6 and 2.0 mmol/min/mg protein, respectively.
The protein content was measured using the Bradford method, with bovine serum albumin as the standard.
20)
Culture of MCF-7 Cells and E-Screen Assay MCF-7 cells were maintained in DMEM containing 10% FBS. Cells were grown at 37°C in a humidified 95% air and 5% CO 2 atmosphere. The cells were washed with phosphate-buffered saline (PBS), and then cultured in phenol red-free DMEM, with 10% CD-FBS, for 2 d to eliminate any estrogenic source prior to treatment.
The cultured cells (5ϫ10 3 cells/well) were seeded in culture flasks, with the medium exchanged 24 h later. The fresh phenol red-free medium contained 5% CD-FBS and the indicated test compounds. After a further 96 h, the phenol redfree medium was exchanged again, and the cells harvested after a further 144 h incubation. The viable cell density numbers were determined using the SRB assay. 21) RNA Extraction and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) MCF-7 cells were cultured with phenol red-free DMEM containing 10% CD-FBS. After 48 h, the cells were treated with 10 mM ginsenoside Re, ginsenoside Rg1, ginsenoside Rh1, protopanaxatriol or 10 nM 17b-estradiol. The treated cells were washed in PBS, and the total RNA isolated using an RNeasy ® Mini Kit (Qiagen, U.S.A.), according to the manufacturer's instruction. To synthesize cDNA, AccuPower RT-PCR Premix (Bioneer, Korea) was used. The sequences of the c-fos primers were 5Ј-TCCCAGAGGAGATGTCTGTG-3Ј and 5Ј-GGCTCCA-GCTCTGTGACCAT-3Ј, those of pS2 were 5Ј-GCGAAG-CTTGGCCACCATGGAGAACAAGG-3Јand 5Ј-GCGGAT-CCACGAACGGTGTCGTCGAA-3Ј, and those of GAPDH were 5Ј-GCCACAGTCCATGCCATCAC-3Ј and 5Ј-TCCAC-CACCCTGTTGCTGTA-3Ј. The PCR product for c-fos, GAPDH and pS2 were 330 bp, 452 bp and 189 bp, respectively. The reactions were initiated by 5 min of denaturation at 94°C, followed by amplification at 94°C for 45 s, 55°C for 45 s and 72°C for 45 s; with 30 cycles for c-fos, 25 for pS2 and 32 for GAPDH. The PCR reactions were terminated by elongation at 72°C for 5 min. The PCR products were analyzed using 2% agarose gel electrophoresis.
Immunoblot MCF-7 cells were cultured in phenol redfree DMEM containing 10% CD-FBS. After 48 h, the cells were treated with 10 mM of each ginsenoside, or 10 nM 17b-estradiol. The treated cells were washed in PBS, and collected cells lysed in lysis buffer [10 mM Tris (pH 8.0), 1.5 mM MgCl 2 , 1 mM DTT, 0.1% NP40 and protease inhibitor cocktail]. After centrifugation at 12000ϫg at 4°C for 15 min, the supernatant was used as the protein fraction. An equal amount of protein (30 mg) for each sample was separated by 12% sodium dodecyl sulfate-polyacrylamide gel and transferred to polyvinylidene difluoride (PVDF) membrane at 30 V for 2 h. The membrane was then blocked with 3% skim milk in PBS/0.05% Tween 20 for 2 h at room temperature. The membrane was then incubated with rabbit anti-human polyclonal antibody to PR for 2 h. After washing with PBS, the blots were incubated with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody and visualized with ECL kits.
RESULTS
Screening of Ginsenoside Re-hydrolyzing Intestinal
Bacteria from Human Feces When the ginsenoside Rehydrolyzing activity in three samples of human feces was preliminarily assayed, all specimens showed activity (Data not shown), this varied dependently between individuals. To investigate the metabolites of ginsenoside Re produced by human intestinal microflora, ginsenoside Re was anaerobically incubated with a human fecal suspension for 24 h, the metabolites then extracted with BuOH and analyzed by TLC. C-NMR analyses these were identified as ginsenosides Rg1, Rh1 and F1 for the major components, with protopanxatriol as the minor.
Therefore, ginsenoside Re was incubated with human fecal suspension and periodically assayed for metabolites. Ginsenoside Re began to be converted to ginsenoside Rg1, and subsequently produced ginsenosides Rh1 and F1, and finally protopanaxatriol after 9 h of incubation. The major metabolites were ginsenosides Rg1, Rh1 and F1, with protopanaxatriol as the minor, following 24 h of incubation. However, ginsenoside Rg2 was not detected.
Five ginsenoside Re-hydrolyzing intestinal bacteria (GHIB) were also isolated from human feces, and assayed for the metabolites of ginsenoside Re. As shown in Table 1 , almost all the GHIB hydrolyzed ginsenoside Re, mainly to ginsenoside Rg1, with ginsenoside Rh1 and F1 as the minor components. The GHIB also metabolized ginsenoside Rg1, mainly to ginsenosides Rh1 and F1, with protopanaxatriol as the minor component. The most potent ginsenoside Re-metabolizing Bacterioides JY-6, an anaerobic, gram-negative, non-spore forming, rod-shaped, a -rhamnosidase-positive, bglucosidase-positive and non-gas productive, mainly transformed the ginsenoside Re to ginsenosides Rh1 and F1, with protopanaxatriol as a minor component.
Substrate Specificity of a a-Rhamnosidase and b b-Glucosidase of Bacteroides JY-6 The most potent ginsenoside Re-hydrolyzing Bacteroides JY-6 was cultured, and a-rhamnosidase and b-glucosidase partially purified, as previously reported, 18, 19) and their substrate specificities investigated (Table 2) . Ginsenoside Re was a good substrate of a-rhamnosidase, although PNR and poncirin were the best substrates. However, this enzyme did not transform ginsenoside Rg1 and poncirenin. Ginsenoside Rg1 was a good substrate of the b-glucosidase, although PNG and poncirenin were also the best substrates. However, b-glucosidase hydrolyzed ginsenosides Rh1 and F1 only weakly compared to ginsenoside Rg1.
Estrogenic Effect of Ginsenoside Re and Its Metabolites The estrogenic activity of ginsenoside Re and its metabolites, ginsenoside Rg1, ginsenoside Rh1 and protopanaxatriol, were investigated. Of these ginsenosides, ginsenoside Rh1 exhibited the most potent estrogenic activity. The ginsenoside Rh1, at a concentration of 1 mM, increased the proliferation of MCF-7 cells 2.1-fold, which was comparable to that of 17 b-estradiol at a concentration of 1 nM.
To evaluate the potential of ginsenoside Re and its metabolites as activators of estrogen-responsive genes, the cfos and pS2 mRNA induction in MCF-7 cells was examined after treatment with these ginsenosides. The steady-state c-fos and pS2 mRNA levels were measured by performing RT-PCR assays on the total RNA prepared from MCF-7 cells treated with these ginsenosides, with constitutively expressed GAPDH mRNA used as an internal control. The c-fos and A human fecal suspension was prepared, and the metabolites of ginsenoside Re assayed, as described in Materials and Methods. ᭹, ginsenoside Re; , ginsenoside Rg1; ᭝, ginsenoside Rg2; ᭡, ginsensoide Rh1; ٗ, Ginsenoside F1; ᭺, protopanaxatriol. pS2 mRNA expressions were induced after 24 h with 17 bestradiol treatment, as is well known. 22) These ginsenosides also activated the transcriptions of the c-fos and pS2 genes, although the effects were not as prominent as those of 17 bestradiol. Among these ginsenosides, ginsenoside Rh1 most potently activated the transcriptions of these genes. To further examine the induction of endogenous estrogen responsive genes due to ginsenoside, the PR protein levels were determined using immunoblot analysis. The PR protein levels were increased after 24 h of treatment with either 17 b-estradiol or ginsenoside Rh1 compared to that of the vehicle treated control. microflora in the alimentary tract. These components may be transformed before they are absorbed from the gastrointestinal tract. Studies on the metabolism of herbal medicine components by human intestinal microflora are; therefore, of great importance in understanding their biological effects. 23, 24) The major components of orally administered ginseng are also metabolized by intestinal microflora and express their pharmacological effects. [8] [9] [10] [11] [12] For example, when ginseng extract was orally administered to humans, ginsenoside F1, compound K and ginsenoside Rh1 were detected in the urine and blood. 14) These results suggest that protopanaxadiol ginsenosides may be metabolized, mainly to compound K, and protopanaxatriol ginsenosides to ginsenoside Rh1 and ginsenoside F1. Thus, these findings are in contrast with the report of Hasegawa et al. who found that ginsenoside Re was mainly metabolized to protopanaxatriol by human intestinal microflora.
15) Therefore, we investigated the metabolic pathway of ginsenoside Re by human intestinal microflora. When ginsenoside Re was incubated with human intestinal microflora for 24 h, it was metabolized mainly to ginsenosides Rh1 and F1, with protopanaxatriol (<5%) as the minor component, but ginsenoside Rg2 could not be detected as a metabolite. This suggestion is supported by the report of Tawab et al. who detected ginsenosides Rh1 and F1 in the blood of humans after the oral administration of ginseng extract. 14) Tawab et al. also suggested that human intestinal microflora may metabolize ginsenosides Rg1 and Rg2 to ginsenosides F1 and Rh1, respectively.
14) The isolated ginsenoside Re-hydrolyzing bacteria mainly metabolized ginsenoside Re to ginsenosides Rh1 and F1. However, the most potent ginsenoside Re-hydrolyzing Bacteroides JY-6 also transformed ginsenoside Re mainly to ginsenosides Rh1 and F1, with protopanaxatriol (Ͻ5%) as a minor component. The arhamnosidase purified from Bacteroides JY-6 catalyzed ginsenoside Re to ginsenoside Rg1. However, b-glucosidase, purified from Bacteroides JY-6, hydrolyzed ginsenoside Rg1 to mainly ginsenoside Rh1, and to ginsenoside F1 and protopanaxatriol as minor components. However, Bifidobacterium K-525 potently metabolized ginsenoside Rg2 to ginsenoside F1 rather than to ginsenoside Rh1. Most ginsenoside Re-metabolizing bacteria did not transform ginsenoside Re to protopanaxatriol. These results suggest that the protopanxatriol saponins, ginsenoside Re and ginsenoside Rg1, may be transformed to mainly ginsenoside Rh1, with ginsenoside F1 as a minor component, by human intestinal microflora (Fig. 4) , although the metabolism of ginsenoside Re can depend on the composition of the intestinal microflora, with the metabolites, ginsenosides Rh1 and F1, absorbable into the blood.
In Korea, Japan and China, ginseng has been used as a tonic, for thousands of years, to fight various aspects of stress and to restore homeostasis. 1) In Western countries, it is being used as an alternative herb for postmenopausal women. Many researchers have reported that ginseng and its saponins exhibit estrogenic activity. 22, 25, 26) Ginseng extracts activate estrogen-responsive genes and regulate the growth of human breast cancer cells. 25) A recent study by Chan et al. showed that ginsenoside-Rg1 activated ER-mediated transcription, without direct receptor interaction. 25) Lee et al. has also reported the estrogenic activity of ginsenoside Rh1. The protopanxatriol ginsenosides have also been shown to exert estrogenic effects. 26) However, the relationship between protopanxatriol ginsenosides and their estrogenic activities has not been reported. When their estrogenic activities were investigated on MCF-7 cells, ginsenoside Rh1 was found to increase the cell proliferation. Ginsenoside Rh1 also activated the transcriptions of the c-fos and pS2 genes, although the effects were not as prominent as those with 17b-estradiol. These results support that ginsenosides can act as weak estrogen receptor agonists.
Based on these findings, we suggest that the protopanxatriol ginsenosides, Re and Rg1, may be metabolized mainly to ginsenosides Rh1 and F1 by intestinal microflora in the intestines, which can be subsequently absorbed into the blood, where they may express their estrogenic effect. , minor pathway.
